These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 2579374)
1. The impact of maternal serum alpha fetoprotein screening on open neural tube defect births in north-east Scotland. Thom H; Campbell AG; Farr V; Fisher PM; Hall MH; Swapp GH; Gray ES Prenat Diagn; 1985; 5(1):15-9. PubMed ID: 2579374 [TBL] [Abstract][Full Text] [Related]
2. Amniotic-fluid alpha-fetoprotein measurement in antenatal diagnosis of anencephaly and open spina bifida in early pregnancy. Second report of the U.K. Collaborative Study on Alpha-fetoprotein in Relation to Neural-tube Defects. Lancet; 1979 Sep; 2(8144):651-62. PubMed ID: 90757 [TBL] [Abstract][Full Text] [Related]
3. A comparison of amniotic fluid alpha-fetoprotein and acetylcholinesterase in the prenatal diagnosis of open neural tube defects and anterior abdominal wall defects. Loft AG; Høgdall E; Larsen SO; Nørgaard-Pedersen B Prenat Diagn; 1993 Feb; 13(2):93-109. PubMed ID: 7681980 [TBL] [Abstract][Full Text] [Related]
4. Midtrimester screening for open neural tube defects: correlation of sonography with amniocentesis results. Lindfors KK; McGahan JP; Tennant FP; Hanson FW; Walter JP AJR Am J Roentgenol; 1987 Jul; 149(1):141-5. PubMed ID: 2438918 [TBL] [Abstract][Full Text] [Related]
5. Results and benefits of a maternal serum alpha-fetoprotein screening program. Milunsky A; Alpert E JAMA; 1984 Sep; 252(11):1438-42. PubMed ID: 6206249 [TBL] [Abstract][Full Text] [Related]
6. Amniotic fluid acetylcholinesterase measurement in the prenatal diagnosis of open neural tube defects. Second report of the Collaborative Acetylcholinesterase Study. Wald N; Cuckle H; Nanchahal K Prenat Diagn; 1989 Dec; 9(12):813-29. PubMed ID: 2483269 [TBL] [Abstract][Full Text] [Related]
7. The use of maternal serum AFP in screening for neural tube defects. Brock DJ UCLA Forum Med Sci; 1978; 20():191-7. PubMed ID: 80861 [No Abstract] [Full Text] [Related]
8. The sensitivity of ultrasound and serum alpha-fetoprotein in population-based antenatal screening for neural tube defects. South Australia 1986-1991. Chan A; Robertson EF; Haan EA; Ranieri E; Keane RJ Br J Obstet Gynaecol; 1995 May; 102(5):370-6. PubMed ID: 7542023 [TBL] [Abstract][Full Text] [Related]
9. Amniotic fluid acetylcholinesterase electrophoresis as a secondary test in the diagnosis of anencephaly and open spina bifida in early pregnancy. Report of the Collaborative acetylcholinesterase Study. Lancet; 1981 Aug; 2(8242):321-4. PubMed ID: 6115108 [TBL] [Abstract][Full Text] [Related]
11. Amniotic fluid alpha-fetoprotein levels and the prenatal diagnosis of neural tube defects: a collaborative study of 2180 pregnancies in the Netherlands. Kleijer WJ; De Bruijn HW; Leschot NJ Br J Obstet Gynaecol; 1978 Jul; 85(7):512-7. PubMed ID: 79418 [TBL] [Abstract][Full Text] [Related]
12. [Prenatal alpha fetoprotein screening for defects in the neural tube]. Grob PJ Schweiz Med Wochenschr; 1978 Aug; 108(34):1302-7. PubMed ID: 80821 [TBL] [Abstract][Full Text] [Related]
13. Antecedent circumstances surrounding neural tube defect births in 1990-1991. The Steering Committee of the National Confidential Enquiry into Counselling for Genetic Disorders. Williamson P; Alberman E; Rodeck C; Fiddler M; Church S; Harris R Br J Obstet Gynaecol; 1997 Jan; 104(1):51-6. PubMed ID: 8988697 [TBL] [Abstract][Full Text] [Related]
14. [Prenatal detection of open neural tube defects in a mass screening program by determination of alpha-fetoprotein concentration in maternal serum]. Zwahr C; Körner H; Tinschert S; Horn A; Schulze M; Voigt M Zentralbl Gynakol; 1988; 110(3):158-67. PubMed ID: 2452529 [TBL] [Abstract][Full Text] [Related]
15. Amniotic fluid alpha-fetoprotein as a marker in prenatal diagnosis of neural tube defects. Weiss RR; Macri JN; Elligers K; Princler GL; McIntire R; Waldman TA Obstet Gynecol; 1976 Feb; 47(2):148-51. PubMed ID: 55990 [TBL] [Abstract][Full Text] [Related]
16. Elevated maternal serum alpha-fetoprotein with normal ultrasound: is amniocentesis always appropriate? A review of 26,069 screened patients. Richards DS; Seeds JW; Katz VL; Lingley LH; Albright SG; Cefalo RC Obstet Gynecol; 1988 Feb; 71(2):203-7. PubMed ID: 2447540 [TBL] [Abstract][Full Text] [Related]
17. Prevalence of neural tube defects in South Australia, 1966-91: effectiveness and impact of prenatal diagnosis. Chan A; Robertson EF; Haan EA; Keane RJ; Ranieri E; Carney A BMJ; 1993 Sep; 307(6906):703-6. PubMed ID: 8401091 [TBL] [Abstract][Full Text] [Related]
18. Antenatal screening in Oxford for fetal neural tube defects. Wald NJ; Cuckle HS; Boreham J; Brett R; Stirrat GM; Bennett MJ; Turnbull AC; Solymar M; Jones N; Bobrow M; Evans CJ Br J Obstet Gynaecol; 1979 Feb; 86(2):91-100. PubMed ID: 85462 [TBL] [Abstract][Full Text] [Related]
19. Maternal serum-alpha-fetoprotein measurement in antenatal screening for anencephaly and spina bifida in early pregnancy. Report of U.K. collaborative study on alpha-fetoprotein in relation to neural-tube defects. Wald NJ; Cuckle H; Brock JH; Peto R; Polani PE; Woodford FP Lancet; 1977 Jun; 1(8026):1323-32. PubMed ID: 69055 [TBL] [Abstract][Full Text] [Related]
20. Diagnostic ultrasound: early detection of fetal neural tube defects. Robinson HP; Hood VD; Adam AH; Gibson AA; Ferguson-Smith MA Obstet Gynecol; 1980 Dec; 56(6):705-10. PubMed ID: 6160439 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]